Log in
Enquire now
Mosanna Therapeutics

Mosanna Therapeutics

Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.

OverviewStructured DataIssuesContributors

Contents

mosanna.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Health technology
Health technology
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Manufacturing
Manufacturing
Location
Switzerland
Switzerland
B2X
B2C
B2C
CEO
David Weber
David Weber
Number of Employees (Ranges)
1 – 10
Email Address
info@mosanna.com
Investors
Forty51 Ventures
Forty51 Ventures
‌
Supermoon Capital
EQT Life Sciences
EQT Life Sciences
Norwest Venture Partners
Norwest Venture Partners
High-Tech Gründerfonds
High-Tech Gründerfonds
Forbion Capital Partners
Forbion Capital Partners
Broadview Ventures
Broadview Ventures
Pivotal bioVenture Partners
Pivotal bioVenture Partners
Founded Date
2022
Total Funding Amount (USD)
80,000,000
Latest Funding Round Date
June 10, 2025
Latest Funding Type
Series A
Series A
Headquarters
Basel
Basel

Other attributes

Latest Funding Round Amount (USD)
80,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Mosanna Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.